Back to results
US 2024/0173384 A1Published application
Treatment of pediatric type 2 diabetes mellitus patients
AssigneeSanofi-Aventis Deutschland GmbH
InventorsKarin Bergmann, Agnes Hincelin-Mery, Christelle Jan
Life of this patent
Estimating the term…
Abstract
The present invention refers to lixisenatide for use in pediatrics.
Claims10
A method of treating type 2 diabetes mellitus in a patient 10-17 years old comprising administering lixisenatide to the patient in need thereof at a dose of 5 μg, 10 μg or 20 μg per day,
- wherein the treatment with lixisenatide reduces the levels of fasting plasma glucose (FPG), post-prandial glucose (PPG), and HbA1C in the patient.
Dependencies are inferred from the claim text.